Results 171 to 180 of about 1,428,732 (361)

Potential Survival Benefit of Adjuvant Chemotherapy in Stage IV Intrahepatic Cholangiocarcinoma: A Multicenter, Stage‐Stratified Analysis

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
This multicenter study suggests that adjuvant chemotherapy may improve survival in stage IV intrahepatic cholangiocarcinoma after resection, with S‐1 showing a potential survival advantage. ABSTRACT Background The survival benefit of adjuvant chemotherapy (AC) in intrahepatic cholangiocarcinoma (ICC) remains uncertain, particularly in advanced‐stage ...
Hisashi Kosaka   +9 more
wiley   +1 more source

Evaluating the impact of Georgia's hepatitis C elimination plan: lessons learned for the global initiative

open access: yesThe Lancet Global Health, 2020
Yvan Hutin   +2 more
doaj   +1 more source

Towards the elimination of viral hepatitis in Thailand by the year 2030

open access: gold, 2020
Nawarat Posuwan   +6 more
openalex   +1 more source

Clinical Course of Infection and Cross-Species Detection of Equine Parvovirus-Hepatitis [PDF]

open access: gold, 2021
Birthe Reinecke   +14 more
openalex   +1 more source

Combination of Ethoxybenzyl‐Diethylenetriamine Pentaacetic Acid‐Enhanced Magnetic Resonance Imaging and a Serum Biomarker Is Useful in the Diagnosis of Hepatic Sinusoidal Disorder After Chemotherapy Treatment

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
ROC analyses of APRI score, EOB‐MRI, and a combination of EOB‐MRI and APRI score for blue liver. ABSTRACT Aim Sinusoidal obstruction syndrome (SOS), also known as “blue liver (BL),” is a common hepatic injury following oxaliplatin‐based chemotherapy in patients with colorectal liver metastases (CRLM).
Tomonari Shimagaki   +7 more
wiley   +1 more source

Epigallocatechin gallate inhibits hepatitis B virus infection in human liver chimeric mice [PDF]

open access: gold, 2018
Yu‐Heng Lai   +5 more
openalex   +1 more source

Effect of alcohol on clinical complications of hepatitis virus-induced liver cirrhosis: a consecutive ten-year study [PDF]

open access: gold, 2022
Kodjo-Kunale Abassa   +5 more
openalex   +1 more source

Unexpectedly High Incidence of Immune‐Related Adverse Events in Gastric Cancer Patients Who Received Conversion Surgery After Nivolumab‐Including Chemotherapy

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
ABSTRACT Background Nivolumab‐including chemotherapy (nivo‐CTX) for stage IV gastric cancer (GC) may increase the chance of conversion surgery but risk of immune‐related adverse events (irAEs) during perioperative period remains unclear. Methods We examined irAEs in 36 patients with marginally resectable GC who received nivo‐CTX followed by surgery ...
Masashi Nishino   +11 more
wiley   +1 more source

Apolipoprotein E polymorphism influences orthotopic liver transplantation outcomes in patients with hepatitis C virus-induced liver cirrhosis

open access: hybrid, 2021
José Carlos Rodrigues Nascimento   +11 more
openalex   +1 more source

Cell Culture Isolation and Whole Genome Characterization of Hepatitis E Virus Strains from Wild Boars in Germany [PDF]

open access: gold, 2021
Katja Schilling‐Loeffler   +6 more
openalex   +1 more source

Home - About - Disclaimer - Privacy